Subject: "United States. Food and Drug Administration." / Format: Microform / Region: United States

Clear Search

You searched for: Subject "United States. Food and Drug Administration." Format Microform Region United States

« Previous | 1 - 10 of 45 | Next »

Financial management : FDA's controls over property have improved, but weaknesses remain : report to Congressional requesters
by United States. General Accounting Office
1999
Format: Book and Microform

✔ Available Joyner - Microforms B300

Call Number: GA 1.13:AIMD-99-51

FDA's FOIA fees
by United States. General Accounting Office
1993
Format: Book and Microform

✔ Available Joyner - Microforms B300

Call Number: GA 1.13:GGD-93-47 R

Medical devices : FDA review times, 1989 through 1996
by United States. General Accounting Office. Health, Education, and Human Services Division
1997
Format: Book and Microform

✔ Available Joyner - Microforms B300

Call Number: GA 1.13:HEHS-97-146 R

FDA drug approval : review time has decreased in recent years : report to congressional requesters
by United States. General Accounting Office
1995
Format: Book and Microform

✔ Available Joyner - Microforms B300

Call Number: GA 1.13:PEMD-96-1

FDA import automation : serious management and systems development problems persist : report to the ranking minority member, Committee on Commerce, House of Representatives
by United States. General Accounting Office
1995
Format: Book and Microform

✔ Available Joyner - Microforms B300

Call Number: GA 1.13:AIMD-95-188

FDA resources
by United States. General Accounting Office. Program Evaluation and Methodology Division
1996
Format: Book and Microform

✔ Available Joyner - Microforms B300

Call Number: GA 1.13:PEMD-96-8 R

✔ Available Joyner - Microforms B300

Call Number: GA 1.5/2:T-NSIAD-00-48

✔ Available Joyner - Microforms B300

Call Number: GA 1.13:RCED-98-103

✔ Available Joyner - Microforms B300

Call Number: GA 1.5/2:T-PEMD-96-9

✔ Available Joyner - Microforms B300

Call Number: GA 1.13:PEMD-94-26

Find materials by

Location

Format

Publication Date

Collection

Language

Genre

Region

Financial management : FDA's controls over property have improved, but weaknesses remain : report to Congressional requesters

FDA's FOIA fees

Medical devices : FDA review times, 1989 through 1996

FDA drug approval : review time has decreased in recent years : report to congressional requesters

FDA import automation : serious management and systems development problems persist : report to the ranking minority member, Committee on Commerce, House of Representatives

FDA resources

Anthrax vaccine : safety and efficacy issues : statement of Kwai-Cheung Chan, Director, Special Studies and Evaluations, National Security and International Affairs Division, before the Committee on Government Reform, House of Representatives

Food safety federal efforts to ensure the safety of imported foods are inconsistent and unreliable : report to the Chairman, Permanent Subcommittee on Investigations, Committee on Governmental Affairs, U.S. Senate

FDA review times : statement of Mary R. Hamilton, Director of Program Evaluation in Human Services Areas, Program Evaluation and Methodology Division, before the Subcommittee on Health and Environment, Committee on Commerce, House of Representatives

FDA user fees : current measures not sufficient for evaluating effect on public health : report to the Chairman, Human Resources and Intergovernmental Relations Subcommittee, Committee on Government Operations, House of Representatives

ECU Libraries Catalog

Find materials by

Search Constraints

Search Results